A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms

Journal of Visualized Experiments

Volumn , Issue 44, 2010, Pages

  Pierce, Christopher G ^a   Uppuluri, Priya ^a   Tummala, Sushma ^a   Lopez Ribot, Jose L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Antifungals; Biofilms; Candida; Candidiasis; Immunology; Issue 44; Medical Mycology; Microbiology

Indexed keywords

EID: 80355133758     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2287     Document Type: Article

References (12)

1. Bachmann, S.P. et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46, 3591-3596. (2002).
2. Hawser, S.P., Norris, H., Jessup, C.J. & Ghannoum, M.A. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 36, 1450-1452 (1998).
3. Kuhn, D.M., Balkis, M., Chandra, J., Mukherjee, P.K. & Ghannoum, M.A. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Microbiol 41, 506-508 (2003).
4. Kuhn, D.M., George, T., Chandra, J., Mukherjee, P.K. & Ghannoum, M.A. Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46, 1773-1780 (2002).
5. Nobile, C.J. & Mitchell, A.P. C. albicans transcription factor Bcr1p: a regulator of cell-surface genes and biofilm formation. Current Biol. 15, 1150-1155 (2005).
6. Ramage, G., Saville, S.P., Thomas, D.P. & Lopez-Ribot, J.L. Candida biofilms: an update. Eukaryot Cell 4, 633-638. (2005).
7. Ramage, G., Vande Walle, K., Wickes, B.L. & Lopez-Ribot, J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45, 2475-2479. (2001).
8. Bachmann, S.P. et al. Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother 47, 3657-3659. (2003).
9. Ramage, G., VandeWalle, K., Bachmann, S.P., Wickes, B.L. & Lopez-Ribot, J.L. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 46, 3634-3636. (2002).
10. Ramage, G., VandeWalle, K., Wickes, B.L. & López-Ribot, J.L. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18, 163-170 (2001).
11. Tellier, R., Krajden, M., Grigoriew, G.A. & Campbell, I. Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob Agents Chemother 36, 1619-1625 (1992).
12. Nett J. & Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol. 9, 340-5 (2006).